Research by Joel Cantor et al. “Access to Hepatitis C Treatment during and after Incarceration in New Jersey, United States: A Qualitative Study”

April 17, 2023

Abstract

Despite effective antiviral therapy for hepatitis C virus (HCV), people who are incarcerated and those returning to the community face challenges in obtaining HCV treatment. We aimed to explore facilitators and barriers to HCV treatment during and after incarceration. From July–November 2020 and June–July 2021, we conducted 27 semi-structured interviews with residents who were formerly incarcerated in jail or prison. The interviews were audio-recorded and professionally transcribed. We used descriptive statistics to characterize the study sample and analyzed qualitative data thematically using an iterative process. Participants included five women and 22 men who self-identified as White (n = 14), Latinx (n = 8), and Black (n = 5). During incarceration, a key facilitator was having sufficient time to complete HCV treatment, and the corresponding barrier was delaying treatment initiation. After incarceration, a key facilitator was connecting with reentry programs (e.g., halfway house or rehabilitation program) that coordinated the treatment logistics and provided support with culturally sensitive staff. Barriers included a lack of insurance coverage and higher-ranking priorities (e.g., managing more immediate reentry challenges such as other comorbidities, employment, housing, and legal issues), low perceived risk of harm related to HCV, and active substance use. Incarceration and reentry pose distinct facilitators and challenges to accessing HCV treatment. These findings signal the need for interventions to improve engagement in HCV care both during and after incarceration to assist in closing the gap of untreated people living with HCV.

Keywords: HCV; Hepatitis C; treatment; direct-acting antiviral DAA; prison; jail; incarceration; linkage to care; qualitative

Citation

Kamat, Samir, Sankeerth Kondapalli, Shumayl Syed, Gabrielle Price, George Danias, Ksenia Gorbenko, Joel Cantor, Pamela Valera, Aakash K. Shah, and Matthew J. Akiyama. 2023. “Access to Hepatitis C Treatment during and after Incarceration in New Jersey, United States: A Qualitative Study” Life 13, no. 4: 1033. https://doi.org/10.3390/life13041033

Recent Posts

Meet the 2026 New Jersey Leadership Collective Fellows

New Jersey Leadership Collective’s mission is to train leaders who are committed to moving the communities they serve and the Garden State forward. They aim to make progressive change to legislation and policies through building collective power and taking collective...

EJB Talks: Fighting for Government Accountability in NJ

From Corruption to Ballot Reform: Fighting for Government Accountability in New Jersey As we close out our 13th season of EJB Talks, Dean Stuart Shapiro asks Public Policy Program Director, Professor Julia Rubin, about why New Jersey has long been considered one of...

New 2024-2025 Health Administration Program Annual Report

Dear Colleagues, This year’s milestone is the successful launch of our Doctor of Health Administration (DHA) program in Fall 2025, welcoming an inaugural cohort of 23 mid- and senior-level healthcare leaders. Designed in an executive-style format, the DHA advances...

Heldrich Center: Updated Multi-State Postsecondary Report Released

The Heldrich Center for Workforce Development has announced the release of an updated Multi-State Postsecondary Report, linking postsecondary completion data to employment outcomes across Kentucky, New Jersey, Ohio, Rhode Island, Tennessee, and Virginia. This effort...

Cantor, Yedidia Identify Strategies to Provide Health Care to Homeless

Through cooperation, homeless services and health care providers can improve delivery of medical care to a vulnerable population, according to Rutgers researchers published by Rutgers Today, December 17, 2025 Author: Greg Bruno Media Contact: Nicole Swenarton, Rutgers...